What's breaking now, across thousands of outlets.
The Nobel laureates “laid the foundation” for a new field of brain research, the award committee wrote. Elsewhere, Roche and CSL cut licensing deals and the FDA endorsed broader use of a Lilly medicine.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Eli Lilly’s Jaypirca has won FDA approval for previously untreated chronic lymphocytic leukemia and small lymphocytic lymphoma.
The company’s next-generation shot surpassed Wall Street’s expectations by matching the effectiveness of vaccines from Pfizer and Merck on nearly all bacterial strains in the first of three Phase 3…
Russian officials insist the situation is under control after reports a lab technician died of plague in Siberia, saying post-mortem tests found no trace.
Speculation has surrounded the death of Daria Shipilova, who worked in a plague research center in Irkutsk.
Lucknow: A medicine procured for Rs 74.09 is being sold with a maximum retail price of Rs 4,980.94 in Uttar Pradesh—a 67-fold gap between its purchase cost and printed price.
Research shows that there may be a third strain of diabetes, one that is particularly affecting certain groups.
